Aug 2, 2019 06:25AM
Jul 29, 2019 09:28AM
Jun 11, 2019 02:35AM
Nov 6, 2018 09:24AM
Aug 9, 2018 01:04AM
Feb 28, 2018 07:30AM
May 22, 2017 05:51AM Barclays Upgrades Mylan (MYL) to Overweight, Sees Approval for Generic Copaxone
Mar 10, 2017 11:00AM
Mar 10, 2017 04:31AM
Jun 14, 2016 03:30PM
Mar 4, 2016 10:30AM
Nov 13, 2015 09:32AM
Sep 21, 2015 07:11AM
Jul 27, 2015 06:07AM Teva Pharma (TEVA) Ends Effort to Acquire Mylan (MYL)
Jul 27, 2015 04:31AM
Jul 23, 2015 09:06AM
Jun 19, 2015 08:35AM
Jun 19, 2015 08:30AM
May 8, 2015 12:40PM
May 5, 2015 08:32AM
May 5, 2015 08:30AM Teva Provides Additional Detail on Proposed Acquisition of Mylan
Apr 29, 2015 04:13PM
Apr 27, 2015 10:38AM
Apr 27, 2015 10:37AM
Apr 22, 2015 08:33AM
Apr 22, 2015 08:30AM
Apr 21, 2015 10:01AM
Apr 21, 2015 08:46AM Teva Pharma (TEVA) Offers $82/Share for Mylan (MYL)
Apr 21, 2015 08:45AM
Mar 30, 2015 09:31AM
Mar 6, 2015 08:00AM
Jul 14, 2014 09:33AM
Oct 14, 2013 10:44AM
Sep 10, 2013 11:00AM
Aug 2, 2013 10:40AM Notable Analyst Rating Changes 08/02: (MYL) (CTXS) (FLT) Upgraded; (MOS) (GME) (VCLK) Downgraded
Jul 24, 2012 04:52PM
Jun 19, 2012 03:48PM
Apr 9, 2012 02:10PM
Mar 15, 2012 10:43AM
Mar 7, 2012 02:07PM
Dec 13, 2011 11:39AM
Dec 9, 2011 01:15PM Barclays Initiating Coverage: A Seamless Approach to Biopharmaceuticals
Sep 28, 2011 11:38AM
May 5, 2011 02:22PM
Mar 21, 2011 01:28PM
Feb 28, 2011 02:36PM
Jul 16, 2010 12:58PM
Jan 8, 2010 10:51AM
Mar 13, 2009 10:16AM David Moenning's Daily State of the Markets: 3/13
Feb 23, 2009 10:31AM

128,264 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All